APA (7th ed.) Citation

A, K., AA, K., M, N., C, B., B, U., J, N., . . . S, C. (2026). Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK. HemaSphere, 10(2), e70312. https://doi.org/10.1002/hem3.70312

Chicago Style (17th ed.) Citation

A, Kuhnl, et al. "Outcomes of Second-line Axicabtagene Ciloleucel for Large B-cell Lymphoma in the UK." HemaSphere 10, no. 2 (2026): e70312. https://doi.org/10.1002/hem3.70312.

MLA (9th ed.) Citation

A, Kuhnl, et al. "Outcomes of Second-line Axicabtagene Ciloleucel for Large B-cell Lymphoma in the UK." HemaSphere, vol. 10, no. 2, 2026, p. e70312, https://doi.org/10.1002/hem3.70312.

Warning: These citations may not always be 100% accurate.